Amgen Inc.
AMGN.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Amgen Inc. is a leading biotechnology company that discovers, develops, manufactures, and delivers innovative human therapeutics. The company focuses on areas of high unmet medical need, leveraging its expertise in molecular biology and recombinant DNA technology to create medicines that address ser...Show More
Better Health for All
20
Amgen's core business is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics for serious illnesses and high unmet medical needs, indicating a strong positive health impact. The company does not appear to generate revenue from products with significant negative health outcomes. As a biotechnology company, nutrition and food safety is not applicable. In terms of clinical trial ethics, Amgen has developed Diversity Action Plans for nearly every Phase 3 clinical trial.
1
An analysis of 31,619 participants across 258 U.S. clinical trials from 2012 to 2022 showed 17% Black or African American participants (compared to 14% U.S. Census)
2
and 3% Asian participants (compared to 6% U.S. Census).
3
Fair Money & Economic Opportunity
0
No evidence available to assess Amgen Inc on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
-20
Amgen faced a $2.2 million settlement for disability discrimination.
1
The company received a perfect score on the Human Rights Campaign Foundation's Corporate Equality Index for LGBTQ+ workplace equality
2
and Gold Recognition on AHA's Workplace Health Achievement Index.
3
Amgen's workforce includes 52% minorities
4
and 52% women,
5
with 32% minority executives
6
and 45% women executives.
7
Safety programs are in place, including ergonomic training and chemical safety procedures.
8
However, specific data on living wage coverage, safety incident rates, and pay equity ratios are not disclosed.
9
Fair Trade & Ethical Sourcing
0
Amgen has a Human Rights Position Statement
1
and a Supplier Code of Conduct,
2
setting expectations for third-party partners to operate ethically and sustainably. Its Supplier Sustainability Program requires suppliers to address ethical, environmental, and social considerations, including labor and human rights.
3
Amgen complies with the California Transparency in Supply Chains Act, which prohibits child, involuntary, and slave labor, and conducts supplier audits to ensure compliance.
4
The company also has a Conflict Minerals Policy requiring supplier traceability.
5
Amgen has partnered with Resilinc to enhance supply chain transparency.
6
The company has committed to doubling its spend with diverse suppliers in the U.S. and tripling its spend with Black-owned businesses by 2023.
7
Honest & Fair Business
0
Amgen Inc. is currently facing a class-action lawsuit alleging it delayed informing shareholders about a $10.7 billion tax liability, which reportedly led to significant declines in share price.
1
A separate class-action lawsuit also claims the company misled investors by hiding over $3 billion in tax liabilities.
2
In 2024, CareFirst BlueCross BlueShield filed an antitrust lawsuit against Amgen, alleging monopoly pricing for its drug Enbrel.
3
In 2023, Amgen finalized a consent order with the FTC to address antitrust concerns related to its acquisition of Horizon Therapeutics, including provisions to prevent leveraging existing drugs to influence insurance coverage.
4
The U.S. Supreme Court also ruled against Amgen in a 2023 patent dispute, stating its patents did not meet the enablement requirement for adequate public disclosure.
5
Historically, in 2012, Amgen settled claims for misbranding its drug Aranesp, incurring $150 million in criminal penalties and $612 million in civil settlements.
6
Kind to Animals
-30
Amgen adheres to the "3 Rs" (Reduction, Refinement, and Replacement) to minimize animal use and enhance welfare.
1
The company develops New Approach Methodologies (NAMs), invests in high-throughput screening, organoids, and computational modeling, and is actively replacing horseshoe crab-derived endotoxin tests.
2
Amgen collaborates with regulatory authorities for alternatives, advocating for these specific welfare standards.
3
In 2023, the company completed a biodiversity risk assessment for facilities and suppliers and partners with non-profits to protect habitats and species.
4
No War, No Weapons
0
Amgen's core business is human therapeutics, and its activities do not imply direct support for militarization, resulting in no revenue from arms or defense contracts. A $100.5 million contract with Veterans Affairs in 2025 was specifically for pharmaceutical products.
1
Consequently, the company has no exposure to controversial or banned weapons. The Amgen Foundation has committed $100,000 to Beirut relief efforts in 2020
2
and provided grants for Ukrainian humanitarian aid in 2022, including establishing a hotline for Ukrainian refugee patients.
3
Amgen was also recognized as a Military Friendly Employer, ranking 12th in 2021 for its support of military veterans.
4
Planet-Friendly Business
-10
Amgen currently sources 90% of its electricity consumption from renewable energy.
1
The company aims to achieve carbon neutrality for its owned and operated facilities by 2027.
2
In 2022, Amgen issued a $750 million green bond to fund projects that reduce its environmental impact.
3
Its Singapore biomanufacturing facility has achieved a 69% reduction in carbon emissions and a 73% reduction in energy consumption, while a new biomanufacturing facility in Ohio meets LEED Gold standards.
4
Respect for Cultures & Communities
0
Amgen has reported no cultural appropriation incidents.
1
Safe & Smart Tech
0
Amgen experienced a data breach in 2024 through its third-party vendor, Sirva Relocation, LLC, which occurred between August and October 2023.
1
Sensitive personal information, including Social Security numbers, passport numbers, financial, and medical data, was exposed.
2
Amgen was notified in August 2024 and responded by assessing the impact and enhancing security measures.
3
The company has established an AI Governance Council, aligned with the NIST Trustworthy AI framework, to ensure AI systems produce valid, ethical, unbiased, and explainable outcomes.
4
Amgen requires annual information protection and compliance training for all staff and contractors, supplemented by role-specific training and internal phishing exercises.
5
The company commits to collecting and using only the minimum necessary personal information for business purposes, sharing it only with individuals who have a legitimate need, and implementing user access management.
6
A Chief Privacy Officer and Global Privacy Compliance team oversee adherence to data protection laws and regulations, including notifying regulators of incidents.
7
Zero Waste & Sustainable Products
-40
Amgen has set a company-wide target to cut waste by 75% from 2019 levels by 2027.
1
The company implements several waste reduction initiatives, including its Ecovation™ program for sustainable facility design that diverts materials from landfills through recycling.
2
A new manufacturing process for LUMAKRAS™ received an EPA award for reducing solvent waste and incorporating a recycling process.
3
Amgen also uses a Green Packaging Assessment Tool
4
and operates a mail-back program for responsible disposal of medical waste.
5
These efforts demonstrate a focus on hazardous waste minimization and proper handling, particularly through solvent waste reduction and responsible medical waste disposal.